Health IT

A new partnership between Argonaut and Ensera aims to untangle complex supply chains for drug-device products, potentially leveling the field for smaller innovators.

Skanska's massive Karlstad hospital project promises a high-tech future, but can a building solve deep-seated healthcare system challenges like staff shortages?

A new pact between BioSTL and the UK's NHS is set to make St. Louis a prime U.S. launchpad for health tech, turning global innovation into local impact.

While biopharma braces for Medicare price negotiations, Halozyme claims immunity. Is its tech-licensing model the new blueprint for resilience or just a loophole?

Aussie biotech ENA Respiratory secures crucial US patents for its novel immune modulator, signaling a major strategic move in the multi-billion dollar fight against COPD.

Beyond headlines of chip wars, a 30-year partnership between Taiwan's ITRI and Europe is quietly building our future in AI, green energy, and robotics.

At HLTH Europe, Saudi Arabia's KFSH revealed more than just a radiology AI. It unveiled a full ecosystem, proving how integrated tech transforms patient care.

Susan Solomon's Tang Prize for her work on the ozone layer isn't just an award. It's a signal pointing to a powerful blueprint for global cooperation.

A breakthrough publication identifies a novel protein, LanCL1, as a key target for neuropathic pain, validating a new class of drugs for millions of sufferers.

Sanofi's latest FDA nod for Tzield isn't just a new drug approval; it's a strategic shift from symptom management to disease modification in Type 1 Diabetes.

A major data breach at Ohio Living exposes sensitive patient and employee data, echoing a past failure and signaling a deepening crisis for the entire sector.

As Angel Yeast marks 40 years, its latest sustainability report reveals a strategic pivot towards biotech and ESG, setting a new industry standard.

Top federal ministers, Canada's new CPHO, and the Fentanyl Czar will unveil updated opioid data and actions. Will it be enough to turn the tide on a crisis?

U.S. hospitals waste billions in usable medication each year. A new partnership shows how AI and a digital marketplace can plug the leak, a crucial move in an era of drug shortages.

A recent 'Salute to Service' night was more than just baseball. It showcased how a healthcare provider is funding vital non-profits changing veterans' lives.

As leaders gather in Kenya, a new push for a UN treaty reveals the staggering economic and environmental cost of untreated sewage, an overlooked crisis.

Australian biotech Gelteq has a gel that makes bitter medicine taste good to dogs. It's more than a pet owner's dream—it's a strategic move in a $47B market.

A Chicago jury's landmark verdict reveals how a single day's delay can lead to a lifetime of paralysis, questioning the very fabric of patient safety.

A silent barrier in diabetes care, 'clinical inertia,' leaves patients at risk. New research shows how empowering pharmacists with targeted education can turn the tide.

In an era of digital sieges on healthcare, one small hospital's CEO is rewriting the playbook, proving that resilience isn't a matter of size but strategy.